Taylor RC, Cullen SP, Martin SJApoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 9: 231-241

Molecular Cell Biology Laboratory, Department of Genetics, The Smurfit Institute, Trinity College, Dublin 2, Ireland.
Nature Reviews Molecular Cell Biology (Impact Factor: 37.81). 04/2008; 9(3):231-41. DOI: 10.1038/nrm2312
Source: PubMed

ABSTRACT Apoptosis is characterized by a series of dramatic perturbations to the cellular architecture that contribute not only to cell death, but also prepare cells for removal by phagocytes and prevent unwanted immune responses. Much of what happens during the demolition phase of apoptosis is orchestrated by members of the caspase family of cysteine proteases. These proteases target several hundred proteins for restricted proteolysis in a controlled manner that minimizes damage and disruption to neighbouring cells and avoids the release of immunostimulatory molecules.

74 Reads
  • Source
    • "The defining features of apoptosis include cell shrinkage, nuclear fragmentation (karyorrhexis), chromatin condensation (pyknosis), and the presence of apoptotic bodies containing nuclear or cytoplasmic material and membrane blebbing . All of those features are due to the proteolytic activity of the cysteine proteases known as caspases (Taylor et al. 2008). In apoptosis, the integrity of the plasma membrane persists until late in the process. "
    [Show abstract] [Hide abstract]
    ABSTRACT: There has been little focus on the promising ability of metal-based nanoparticles (NPs) to kill cancer cells while sparing normal cells. Many in vitro and in vivo reports suggest that certain metal-based NPs are able to induce apoptosis and autophagy in cancer cells at specific concentrations that are not significantly toxic to non-cancerous cells. Those NPs are thought to exploit the oxidative stress conditions that prevail in cancer cells, which are largely exhausted of antioxidant ability. This review considers the induction of reactive oxygen species (ROS) by metal-based NPs as a mechanism for the specific killing of cancer cells. The article concomitantly provides a comprehensive description of the important pathways and molecules leading to programmed cell death (PCD), which occurs mainly via apoptosis, autophagy, and necroptosis. The PCD pathways are followed as ROS-burdened cancer cells succumb to ROS-generating metal-based NPs. Exploration of nanotechnology interventions in anticancer therapy demands further research into the mechanism of intracellular induction of ROS by metal-based NPs. Furthermore, the induction of ROS by NPs should be strictly controlled if ROS-based therapy is to become a paradigm in cancer therapy.
    Archives of Toxicology 07/2015; DOI:10.1007/s00204-015-1570-1 · 5.98 Impact Factor
  • Source
    • "During the last few years, an extensive research of apoptosis becomes increasingly publicized (Elmore, 2007; Lockshin and Zakeri, 2007; Fulda, 2008; 2009; 2010; Li, 2008; Fulda and Debatin, 2008; Taylor et al., 2008; Vazquez et al., 2008; Youle and Strasser, 2008; Chen and Pervaiz, 2009; Deng et al., 2009; Engel and Henshall, 2009; Lu and El-Deiry, 2009; Circu and Aw; 2010; da Fonseca et al., 2010; Fulda and Pervaiz, 2010; Galluzzi et al., 2010; Lamkanfi and Kanneganti, 2010; Speidel, 2010). This wealth of literature is elaborated for investigating the mechanisms by which different proteins and enzymes are altered and consequently lead to deregulation of apoptosis that is implicated in different diseases (Zhivotovsky and Orrenius, 2010) such as cancers (Chen and Lai, 2009; Buggins and Pepper, 2010; Pennarun et al., 2010), immunologic disorders (Elkon, 2006; Muñoz et al., 2010), neurodegenerative diseases (Yin and Dong, 2003), respiratory diseases; COPD (Makriset et al., 2009), pulmonary hypertension (Jurasz et al., 2010), acute respiratory Distress Syndrome (ARDS) (Galani et al., 2010) and many others. "
  • Source
    • "There are two pathways that result in apoptosis depending on the apoptotic signal. The extrinsic pathway is initiated by ligand binding to membrane receptors of the death receptor family, whereas the intrinsic pathway is mediated by stress-mediated damage such as alterations in temperature, osmolality, DNA damaging agents, free radical generation compounds, removal of nutrients, and oxygen deprivation (Duprez et al., 2009; Taylor et al., 2008). The activation of the two pathways leads to the same type of apoptotic response, causing release of cytochrome c (Cyt-C) from mitochondria and activation of the executioner caspase-3 (Duprez et al., 2009; Taylor et al., 2008). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Human cord blood (CB) is enriched in circulating endothelial colony forming cells (ECFC) that display high proliferative potential and in vivo vessel forming ability. Since diminished ECFC survival is known to dampen the vasculogenic response in vivo, we tested how long implanted ECFC survive and generate vessels in three-dimensional (3D) type I collagen matrices in vitro and in vivo. We hypothesized that human platelet lysate (HPL) would promote cell survival and enhance vasculogenesis in the 3D collagen matrices. We report that the percentage of ECFC co-cultured with HPL that were alive was significantly enhanced on days 1 and 3 post- matrix formation, compared to ECFC alone containing matrices. Also, co-culture of ECFC with HPL displayed significantly more vasculogenic activity compared to ECFC alone and expressed significantly more pro-survival molecules (pAkt, p-Bad and Bcl-xL) in the 3D collagen matrices in vitro. Treatment with Akt1 inhibitor (A-674563), Akt2 inhibitor (CCT128930) and Bcl-xL inhibitor (ABT-263/Navitoclax) significantly decreased the cell survival and vasculogenesis of ECFC co-cultured with or without HPL and implicated activation of the Akt1 pathway as the critical mediator of the HPL effect on ECFC in vitro. A significantly greater average vessel number and total vascular area of human CD31(+) vessels were present in implants containing ECFC and HPL, compared to the ECFC alone implants in vivo. We conclude that implantation of ECFC with HPL in vivo promotes vasculogenesis and augments blood vessel formation via diminishing apoptosis of the implanted ECFC. Copyright © 2015. Published by Elsevier Inc.
    Microvascular Research 06/2015; 101. DOI:10.1016/j.mvr.2015.06.006 · 2.13 Impact Factor
Show more